Topical Antibacterial Agents

Infectious Disease Clinics of North America

Volumn 23, Issue 4, 2009, Pages 945-963

  Lio, Peter A ^a   Kaye, Elaine T ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Antiseptics; Bacitracin; Gentamicin; Mupirocin; Neomycin; Polymyxin

Indexed keywords

ALCOHOL; ANTI ACNE AGENT; AZELAIC ACID; BACITRACIN; BACITRACIN ZINC; BENZALKONIUM CHLORIDE; BENZOYL PEROXIDE; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; DAPSONE; ERYTHROMYCIN; FRAMYCETIN; GENTAMICIN; HEXACHLOROPHENE; HYDROGEN PEROXIDE; HYPOCHLORITE; HYPOCHLORITE SODIUM; IODOPHOR; NEOMYCIN; POLYMYXIN; POLYMYXIN B; POLYSPORIN; POVIDONE IODINE; PSEUDOMONIC ACID; RETAPAMULIN; SULFADIAZINE SILVER; TOPICAL ANTIINFECTIVE AGENT; TRICLOSAN; UNINDEXED DRUG; ZINC;

ACNE; ACNE VULGARIS; ANTIMICROBIAL ACTIVITY; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BURN INFECTION; CATHETER INFECTION; CLINICAL TRIAL; CONTACT DERMATITIS; CRYSTALLURIA; DRUG BINDING; DRUG DOSAGE FORM COMPARISON; DRUG MECHANISM; DRUG TISSUE LEVEL; ECZEMA; ENDEMIC DISEASE; ERYTHEMA MULTIFORME; ERYTHRASMA; FOLLICULITIS; HAND WASHING; HOSPITAL INFECTION; HUMAN; IMPETIGO; INFECTION CONTROL; KERATOLYSIS; METABOLIC ACIDOSIS; METHEMOGLOBINEMIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MYCOSIS; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; NONHUMAN; OTOTOXICITY; PERSONAL HYGIENE; PREOPERATIVE CARE; PRURITUS; PSEUDOMONAS INFECTION; PYODERMA; REVIEW; ROSACEA; SECONDARY INFECTION; SEXUALLY TRANSMITTED DISEASE; SKIN ALLERGY; SKIN DECONTAMINATION; SKIN FLORA; SKIN INFECTION; SKIN ULCER; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; SYSTEMIC DISEASE; TERATOGENESIS; WOUND CARE; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

ADMINISTRATION, CUTANEOUS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; HANDWASHING; HUMANS; SKIN; SKIN DISEASES, BACTERIAL; WOUNDS AND INJURIES;

EID: 70449508667     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2009.06.006     Document Type: Review

References (121)

1. Jones M.E., Karlowsky J.A., Draghi D.C., et al. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int J Antimicrob Agents 22 4 (2003) 406-419
2. Larson E.L., Butz A.M., Gullette D.L., et al. Alcohol for surgical scrubbing?. Infect Control Hosp Epidemiol 11 3 (1990) 139-143
3. Fuursted K., Hjort A., and Knudsen L. Evaluation of bactericidal activity and lag of regrowth (postantibiotic effect) of five antiseptics on nine bacterial pathogens. J Antimicrob Chemother 40 2 (1997) 221-226
4. Tatnall F.M., Leigh I.M., and Gibson J.R. Comparative study of antiseptic toxicity on basal keratinocytes, transformed human keratinocytes and fibroblasts. Skin Pharmacol 3 3 (1990) 157-163
5. Pericone C.D., Park S., Imlay J.A., et al. Factors contributing to hydrogen peroxide resistance in Streptococcus pneumoniae include pyruvate oxidase (spxb) and avoidance of the toxic effects of the Fenton reaction. J Bacteriol 185 23 (2003) 6815-6825
6. Repine J.E., Fox R.B., and Berger E.M. Hydrogen peroxide kills Staphylococcus aureus by reacting with staphylococcal iron to form hydroxyl radical. J Biol Chem 256 14 (1981) 7094-7096
7. Best M., Springthorpe V.S., and Sattar S.A. Feasibility of a combined carrier test for disinfectants: studies with a mixture of five types of microorganisms. Am J Infect Control 22 3 (1994) 152-162
8. Lau W.Y., and Wong S.H. Randomized, prospective trial of topical hydrogen peroxide in appendectomy wound infection. High risk factors. Am J Surg 142 3 (1981) 393-397
9. O'Toole E.A., Goel M., and Woodley D.T. Hydrogen peroxide inhibits human keratinocyte migration. Dermatol Surg 22 6 (1996) 525-529
10. Milstone A.M., Passaretti C.L., and Perl T.M. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 46 2 (2008) 274-281
11. Nicoletti G., Boghossian V., Gurevitch F., et al. The antimicrobial activity in vitro of chlorhexidine, a mixture of isothiazolinones ('kathon' cg) and cetyl trimethyl ammonium bromide (ctab). J Hosp Infect 23 2 (1993) 87-111
12. Hibbard J.S., Mulberry G.K., and Brady A.R. A clinical study comparing the skin antisepsis and safety of chloraprep, 70% isopropyl alcohol, and 2% aqueous chlorhexidine. J Infus Nurs 25 4 (2002) 244-249
13. Tattawasart U., Hann A.C., Maillard J.Y., et al. Cytological changes in chlorhexidine-resistant isolates of Pseudomonas stutzeri. J Antimicrob Chemother 45 2 (2000) 145-152
14. Kaul A.F., and Jewett J.F. Agents and techniques for disinfection of the skin. Surg Gynecol Obstet 152 5 (1981) 677-685
15. Mermel L. Choice of disinfectants in obtaining blood cultures. Pediatr Infect Dis J 13 5 (1994) 425-426
16. Sandri A.M., Dalarosa M.G., Ruschel de Alcantara L., et al. Reduction in incidence of nosocomial methicillin-resistant staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 27 2 (2006) 185-187
17. Wendt C., Schinke S., Wurttemberger M., et al. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 28 9 (2007) 1036-1043
18. Vernon M.O., Hayden M.K., Trick W.E., et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 166 3 (2006) 306-312
19. Levy I., Katz J., Solter E., et al. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study. Pediatr Infect Dis J 24 8 (2005) 676-679
20. Rupp M.E., Lisco S.J., Lipsett P.A., et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 143 8 (2005) 570-580
21. Chlebicki M.P., and Safdar N. Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 35 2 (2007) 595-602
22. Heath R.J., Rubin J.R., Holland D.R., et al. Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chem 274 16 (1999) 11110-11114
23. Noronha C., and Almeida A. Local burn treatments-topical antimicrobial agents. Ann Burn Fire Disasters 8 4 (2000) 216-219
24. Ward R.S., and Saffle J.R. Topical agents in burn and wound care. Phys Ther 75 6 (1995) 526-538
25. Gocke D.J., Ponticas S., and Pollack W. In vitro studies of the killing of clinical isolates by povidone-iodine solutions. J Hosp Infect 6 Suppl A (1985) 59-66
26. Fleischer W., and Reimer K. Povidone-iodine in antisepsis-state of the art. Dermatology 195 Suppl 2 (1997) 3-9
27. Niedner R. Cytotoxicity and sensitization of povidone-iodine and other frequently used anti-infective agents. Dermatology 195 Suppl 2 (1997) 89-92
28. Kramer S.A. Effect of povidone-iodine on wound healing: a review. J Vasc Nurs 17 1 (1999) 17-23
29. Hsu S., and Quan L. Topical antibacterial agents. In: Wolverton S.E. (Ed). Comprehenisve dermatologic drug therapy (2001), WB Saunders, Phildelphia 472-496
30. Harkaway K.S., McGinley K.J., Foglia A.N., et al. Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br J Dermatol 126 6 (1992) 586-590
31. Gelmetti C. Local antibiotics in dermatology. Dermatol Ther 21 3 (2008) 187-195
32. Barillo D.J. Topical antimicrobials in burn wound care: a recent history. Wounds 20 (2008) 192-198
33. Jacin B. Bleach baths fights S. aureus infections in eczema patients. Pediatr News 41 7 (2007) 58
34. Kaplan S.L. Commentary: prevention of recurrent staphylococcal infections. Pediatr Infect Dis J 27 10 (2008) 935-937
35. Fisher R.G., Chain R.L., Hair P.S., et al. Hypochlorite killing of community-associated methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 27 10 (2008) 934-935
36. Nagai K., Murata T., Ohta S., et al. Two different mechanisms are involved in the extremely high-level benzalkonium chloride resistance of a Pseudomonas fluorescens strain. Microbiol Immunol 47 10 (2003) 709-715
37. Halling H. Suspected link between exposure to hexachlorophene and malformed infants. Ann N Y Acad Sci 320 (1979) 426-435
38. Thuille N., Fille M., and Nagl M. Bactericidal activity of herbal extracts. Int J Hyg Environ Health 206 3 (2003) 217-221
39. Kalemba D., and Kunicka A. Antibacterial and antifungal properties of essential oils. Curr Med Chem 10 10 (2003) 813-829
40. Pappa K.A. The clinical development of mupirocin. J Am Acad Dermatol 22 5 Pt 1 (1990) 873-879
41. Spann C.T., Tutrone W.D., Weinberg J.M., et al. Topical antibacterial agents for wound care: a primer. Dermatol Surg 29 6 (2003) 620-626
42. Antonio M., McFerran N., and Pallen M.J. Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 46 2 (2002) 438-442
43. Jones J.C., Rogers T.J., Brookmeyer P., et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 45 5 (2007) 541-547
44. Walker E.S., Vasquez J.E., Dula R., et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?. Infect Control Hosp Epidemiol 24 5 (2003) 342-346
45. Koning S., van der Wouden J.C., Chosidow O., et al. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. Br J Dermatol 158 5 (2008) 1077-1082
46. Woodford N., Afzal-Shah M., Warner M., et al. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin. J Antimicrob Chemother 62 4 (2008) 766-768
47. Wolf R., Matz H., Orion E., et al. Dapsone. Dermatol Online J 8 1 (2002)
48. Draelos Z.D., Carter E., Maloney J.M., et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol 56 3 (2007) 439 e1-10
49. Wolf R., and Orni-Wasserlauf R. A century of the synthesis of dapsone: its anti-infective capacity now and then. Int J Dermatol 39 10 (2000) 779-783
50. Gette M.T., Marks Jr. J.G., and Maloney M.E. Frequency of postoperative allergic contact dermatitis to topical antibiotics. Arch Dermatol 128 3 (1992) 365-367
51. Leyden J.J. The role of topical antibiotics in dermatologic practice. Medscape. Available at:. http://www.medscape.com/viewprogram/2501 Accessed November 30, 2008
52. Winkelman W., and Gratton D. Topical antibacterials. Clin Dermatol 7 3 (1989) 156-162
53. Kuznar W. Allergen of the year: reactions to common antibiotic bacitracin may be on the rise. Dermatology times (2003, June 1). Available at: http://www.modernmedicine.com/modernmedicine/article/articledetail.Jsp?T s=1228065479155&id=60907 Accessed November 30, 2008
54. Jacob S.E., and James W.D. From road rash to top allergen in a flash: bacitracin. Dermatol Surg 30 4 Pt 1 (2004) 521-524
55. Hendley J.O., and Ashe K.M. Eradication of resident bacteria of normal human skin by antimicrobial ointment. Antimicrob Agents Chemother 47 6 (2003) 1988-1990
56. Hammond B., Ali Y., Fendler E., et al. Effect of hand sanitizer use on elementary school absenteeism. Am J Infect Control 28 5 (2000) 340-346
57. Boyce J.M. Using alcohol for hand antisepsis: dispelling old myths. Infect Control Hosp Epidemiol 21 7 (2000) 438-441
58. Paulson D.S., Fendler E.J., Dolan M.J., et al. A close look at alcohol gel as an antimicrobial sanitizing agent. Am J Infect Control 27 4 (1999) 332-338
59. Girou E., Loyeau S., Legrand P., et al. Efficacy of handrubbing with alcohol-based solution versus standard handwashing with antiseptic soap: randomised clinical trial. BMJ 325 7360 (2002) 362
60. Hilburn J., Hammond B.S., Fendler E.J., et al. Use of alcohol hand sanitizer as an infection control strategy in an acute care facility. Am J Infect Control 31 2 (2003) 109-116
61. White C., Kolble R., Carlson R., et al. The effect of hand hygiene on illness rate among students in university residence halls. Am J Infect Control 31 6 (2003) 364-370
62. Gruendemann B.J., and Bjerke N.B. Is it time for brushless scrubbing with an alcohol-based agent?. AORN J 74 6 (2001) 859-873
63. Laupland K.B., and Conly J.M. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis 37 7 (2003) 933-938
64. von Eiff C., Becker K., Machka K., et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N Engl J Med 344 1 (2001) 11-16
65. Bradley S.F. Effectiveness of mupirocin in the control of methicillin-resistant Staphylococcus aureus. Infect Med 10 (1993) 23-31
66. Perl T.M., Cullen J.J., Wenzel R.P., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 346 24 (2002) 1871-1877
67. Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol 7 11 (1996) 2403-2408
68. Wertheim H.F., Vos M.C., Ott A., et al. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Ann Intern Med 140 6 (2004) 419-425
69. Chambers III H.F., and Winston L.G. Mupirocin prophylaxis misses by a nose. Ann Intern Med 140 6 (2004) 484-485
70. Gorwitz R.J., Kruszon-Moran D., McAllister S.K., et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 197 9 (2008) 1226-1234
71. Datta R., and Huang S.S. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 47 2 (2008) 176-181
72. Mayall B., Martin R., Keenan A.M., et al. Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillin-resistant Staphylococcus aureus in an open ward. J Hosp Infect 32 4 (1996) 257-266
73. Watanabe H., Masaki H., Asoh N., et al. Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 39 10 (2001) 3775-3777
74. Fung S., O'Grady S., Kennedy C., et al. The utility of polysporin ointment in the eradication of methicillin-resistant Staphylococcus aureus colonization: a pilot study. Infect Control Hosp Epidemiol 21 10 (2000) 653-655
75. Jeyaratnam D., Gottlieb A., Ajoku U., et al. Validation of the IDI-MRSA system for use on pooled nose, axilla, and groin swabs and single swabs from other screening sites. Diagn Microbiol Infect Dis 61 1 (2008) 1-5
76. Simor A.E., Phillips E., McGeer A., et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 44 2 (2007) 178-185
77. Fung S.K., Louie M., and Simor A.E. Combined topical and oral antimicrobial therapy for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) colonization in hospitalized patients. Can J Infect Dis 13 5 (2002) 287-292
78. Kokai-Kun J.F., Walsh S.M., Chanturiya T., et al. Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob Agents Chemother 47 5 (2003) 1589-1597
79. LaPlante K.L. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 57 4 (2007) 413-418
80. Caelli M., Porteous J., Carson C.F., et al. Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. J Hosp Infect 46 3 (2000) 236-237
81. McMahon M.A., Blair I.S., Moore J.E., et al. Habituation to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia) is associated with reduced susceptibility to antibiotics in human pathogens. J Antimicrob Chemother 59 1 (2007) 125-127
82. McMahon M.A., Tunney M.M., Moore J.E., et al. Changes in antibiotic susceptibility in staphylococci habituated to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia). Lett Appl Microbiol 47 4 (2008) 263-268
83. Langford J.H., Artemi P., and Benrimoj S.I. Topical antimicrobial prophylaxis in minor wounds. Ann Pharmacother 31 5 (1997) 559-563
84. Maddox J.S., Ware J.C., and Dillon Jr. H.C. The natural history of streptococcal skin infection: prevention with topical antibiotics. J Am Acad Dermatol 13 2 Pt 1 (1985) 207-212
85. Geronemus R.G., Mertz P.M., and Eaglstein W.H. Wound healing. The effects of topical antimicrobial agents. Arch Dermatol 115 11 (1979) 1311-1314
86. Berger R.S., Pappert A.S., Van Zile P.S., et al. A newly formulated topical triple-antibiotic ointment minimizes scarring. Cutis 65 6 (2000) 401-404
87. Proposed recommended practices for surgical skin preparation. Association of operating room nurses. AORN J 63 1 (1996) 221-227
88. Gilmore O.J., Martin T.D., and Fletcher B.N. Prevention of wound infection after appendicectomy. Lancet 1 7797 (1973) 220-222
89. Garibaldi R.A. Prevention of intraoperative wound contamination with chlorhexidine shower and scrub. J Hosp Infect 11 Suppl B (1988) 5-9
90. de Jong T.E., Vierhout R.J., and van Vroonhoven T.J. Povidone-iodine irrigation of the subcutaneous tissue to prevent surgical wound infections. Surg Gynecol Obstet 155 2 (1982) 221-224
91. Rogers D.M., Blouin G.S., and O'Leary J.P. Povidone-iodine wound irrigation and wound sepsis. Surg Gynecol Obstet 157 5 (1983) 426-430
92. Tatnall F.M., Leigh I.M., and Gibson J.R. Assay of antiseptic agents in cell culture: conditions affecting cytotoxicity. J Hosp Infect 17 4 (1991) 287-296
93. Brown C.D., and Zitelli J.A. A review of topical agents for wounds and methods of wounding. Guidelines for wound management. J Dermatol Surg Oncol 19 8 (1993) 732-737
94. Leyden J.J., and Kligman A.M. Rationale for topical antibiotics. Cutis 22 4 (1978) 515-520 22-8
95. Watcher M.A., and Wheeland R.G. The role of topical agents in the healing of full-thickness wounds. J Dermatol Surg Oncol 15 11 (1989) 1188-1195
96. Forbes G.B. Staphylococcal infection of operation wounds with special reference to topical antibiotic prophylaxis. Lancet 2 (1961) 505
97. Fielding G., Rao A., Davis N.C., et al. Prophylactic topical use of antibiotics in surgical wounds: a controlled clinical trial using "Polybactrin". Med J Aust 2 4 (1965) 159-161
98. Gisby J., and Bryant J. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. Antimicrob Agents Chemother 44 2 (2000) 255-260
99. Wahdan H.A. Causes of the antimicrobial activity of honey. Infection 26 1 (1998) 26-31
100. Moore O.A., Smith L.A., Campbell F., et al. Systematic review of the use of honey as a wound dressing. BMC Complement Altern Med 1 2 (2001)
101. Fraser J.F., Bodman J., Sturgess R., et al. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Burns 30 1 (2004) 35-41
102. Singer A.J., and Dagum A.B. Current management of acute cutaneous wounds. N Engl J Med 359 10 (2008) 1037-1046
103. Chung J.Y., and Herbert M.E. Myth: silver sulfadiazine is the best treatment for minor burns. West J Med 175 3 (2001) 205-206
104. Rode H., Hanslo D., de Wet P.M., et al. Efficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infection. Antimicrob Agents Chemother 33 8 (1989) 1358-1361
105. Sinha R., Agarwal R.K., and Agarwal M. Povidone iodine plus neosporin in superficial burns-a continuing study. Burns 23 7-8 (1997) 626-628
106. Subrahmanyam M. A prospective randomised clinical and histological study of superficial burn wound healing with honey and silver sulfadiazine. Burns 24 2 (1998) 157-161
107. Kwakman P.H., Van den Akker J.P., Guclu A., et al. Medical-grade honey kills antibiotic-resistant bacteria in vitro and eradicates skin colonization. Clin Infect Dis 46 11 (2008) 1677-1682
108. Feng Q.L., Wu J., Chen G.Q., et al. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 52 4 (2000) 662-668
109. MacKeen P.C., Person S., Warner S.C., et al. Silver-coated nylon fiber as an antibacterial agent. Antimicrob Agents Chemother 31 1 (1987) 93-99
110. George A., and Rubin G. A systematic review and meta-analysis of treatments for impetigo. Br J Gen Pract 53 491 (2003) 480-487
111. Mertz P.M., Marshall D.A., Eaglstein W.H., et al. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. Arch Dermatol 125 8 (1989) 1069-1073
112. Rist T., Parish L.C., Capin L.R., et al. A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema. Clin Exp Dermatol 27 1 (2002) 14-20
113. O'Meara S.M., Cullum N.A., Majid M., et al. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg 88 1 (2001) 4-21
114. Saji M., Taguchi S., Uchiyama K., et al. Efficacy of gentian violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. J Hosp Infect 31 3 (1995) 225-228
115. Walker J.R., Shafiq N.A., and Allen R.G. Bacterial cell division regulation: physiological effects of crystal violet on Escherichia coli lon + and lon - strains. J Bacteriol 108 3 (1971) 1296-1303
116. Natarajan S., Williamson D., Grey J., et al. Healing of an MRSA-colonized, hydroxyurea-induced leg ulcer with honey. J Dermatolog Treat 12 1 (2001) 33-36
117. Kanj L.F., and Phillips T.J. Management of leg ulcers. Fitzpatrick's J Clin Dermatol (1994) 52-60
118. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis 37 6 (2003) 764-771
119. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 136 11 (2002) 792-801
120. Zinner S.H., Denny-Brown B.C., Braun P., et al. Risk of infection with intravenous indwelling catheters: effect of application of antibiotic ointment. J Infect Dis 120 5 (1969) 616-619
121. Maki D.G., and Band J.D. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 70 3 (1981) 739-744